S
AN FRANCISCO — In 2016, executives at the buzzy telemedicine startup Nurx spoke openly about their ambitions. By the following year, the company’s online services for birth control and the HIV prevention pill would be available in all 50 states.
That never happened. Today, Nurx operates in just 17 states and Washington, D.C.
Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!
SUBSCRIBE TODAYWhat is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
What's included?
- Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
- Subscriber-only networking events and panel discussions across the country
- Monthly subscriber-only live chats with our reporters and experts in the field
- Discounted tickets to industry events and early-bird access to industry reports
About the Author
